Strengthening AR Detection & Reporting in Brazil

CDC helps hospitals & labs rapidly detect & respond to critical AR threats

In Brazil, CDC and Partners Show Early Successes in Improving AR Surveillance Increased lab capacity is driving better detection and enhancing patient care

CDC’s investments in domestic and global partnerships are critical to help combat antimicrobial resistance (AR). As part of CDC’s Global Antimicrobial Resistance Laboratory & Response Network, the Oswaldo Cruz Foundation (FIOCRUZ), through the Foundation for Scientific Technological Development in Health (FIOTEC), is supporting Brazil’s National Public Health Laboratory Network to strengthen AR detection and reporting in Brazil.  The collaboration has enabled laboratories to get needed supplies to detect AR genes, implement standardized procedures for lab testing, and train staff. The resulting improvements in AR detection and reporting can help clinicians make better treatment choices for patients and guide antimicrobial-resistant infection prevention and response activities—all of which protect patient safety.

Building upon the success of the first year of collaboration, CDC is supporting FIOTEC to expand the project across all five regions in Brazil. Read more about how laboratories in Brazil, with partner support, built capacity for AR data collection.

	CDC & partners are helping labs in Brazil better detect & rapidly report critical #AntimicrobialResistance threats through CDC’s Global AR Lab & Response Network. Read the full story for more on this successful partnership: https://bit.ly/43jdDOS

Receive this from a friend? Sign up by entering your email address here.

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe